Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Structure-activity relationship analysis].

Yoichi Hayakawa1

  • 1Institute of Molecular and Cellular Biosciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 30, 2004
PubMed
Summary

Researchers analyzed anticancer drug structures and their activity. Novel compounds targeting tubulin polymerization and topoisomerase I were identified as potential leads for new cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stress-induced organismal death is genetically regulated by the mTOR-Zeste-Phae1 axis.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Drosophila cytokine GBP2 exerts immune responses and regulates GBP1 expression through GPCR receptor Mthl10.

Insect biochemistry and molecular biology·2024
Same author

Booklice Liposcelis bostrychophila are efficiently attracted by the combination of 2,3,5,6-tetramethylpyrazine and ultraviolet light.

Pest management science·2023
Same author

N-acetyloxfenicine strongly induces mitohormesis in mice as well as in insects.

FEBS letters·2022
Same author

Prodigiosin R3, a new multicyclic prodigiosin formed by prodigiosin cyclization genes in the roseophilin producer.

The Journal of antibiotics·2022
Same author

13-Deoxo-13-iminodutomycin, a new neuroprotective compound from Streptomyces sp. RAP78.

The Journal of antibiotics·2021

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Anticancer drug development relies on understanding structure-activity relationships (SAR).
  • Identifying novel mechanisms of action is crucial for overcoming drug resistance.

Purpose of the Study:

  • To classify anticancer drug candidates based on structural features.
  • To analyze SAR for protein kinase inhibitors, tubulin binders, and topoisomerase inhibitors.
  • To identify novel lead compounds for anticancer drug development.

Main Methods:

  • Classification of drug samples by structural features.
  • Analysis of structure-activity relationships for various compound classes.
  • Evaluation of compound correlations with known targets (protein kinases, tubulin, topoisomerase I).

Main Results:

  • Synthetic gymnastatin analogs showed altered protein kinase selectivity based on fatty acid chain length.
  • A novel tubulin depolymerization inhibitor (JCI: 11578) correlated with known binders.
  • Novel tubulin polymerization inhibitors (JCI: 11534, JCI: 11675, JCI: 11676) showed poor correlation with known binders.
  • Compounds JCI: 11403 and JCI: 11407 selectively inhibited topoisomerase I, suggesting a new inhibitor family.

Conclusions:

  • The identified compounds represent potential new families of anticancer agents.
  • These compounds are valuable for further SAR analysis and as lead structures for novel anticancer drug discovery.
  • Targeting tubulin and topoisomerase I remains a promising strategy in cancer therapy research.

Related Experiment Videos